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Abstract 
 
Opioid neurotransmission modulates pain and negative affect during psychological stress. 
To determine whether these effects differ between men and women, the opioid receptor 
antagonist naltrexone or placebo was administered double-blind to 21 men and 22 women 
before they completed 30 minutes of difficult mental arithmetic. To heighten negative 
affect, participants received seven moderately noxious electric shocks during the math 
task, which were believed to be contingent upon performance. Before and after the math 
task, participants rated pain intensity and unpleasantness while their left hand was 
immersed in 2oC water for up to 4 minutes. Anxiety, discouragement and anger were also 
rated before, during and after the math task. Tolerance of cold-induced pain was greater 
in men, whereas discouragement during the math task was greater in women. Opioid 
blockade did not influence ratings of negative affect, which increased in line with the 
intensity and unpleasantness of shock-induced pain. The intensity and unpleasantness of 
cold-induced pain increased after the math task only in women administered naltrexone. 
Within the naltrexone condition, pain ratings increased most in the most discouraged 
subjects. However, this relationship was absent in placebo recipients, implying that the 
hyperalgesic effect of psychological distress was tempered by opioid release. Greater 
stress-evoked discouragement in women than men may explain why cold-induced pain 
increased after the math task only in women administered naltrexone. 
Key words: opioid neurotransmission; naltrexone; psychological stress; discouragement; 
sex effects 
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Introduction 
Uncontrollable aversive events evoke stress-induced analgesia (Amit and Galina, 
1986; Fields and Basbaum, 1999) due, in part, to an increase in µ-opioid receptor-
mediated neurotransmission in cortical and subcortical pain control circuits (Ribeiro et 
al., 2005). Bandura et al. (1988) reported that an intense cognitive stressor triggered an 
opioid-mediated increase in tolerance of cold-induced pain in distressed subjects, whilst 
this response was absent in subjects who could cope with task demands. Similarly, 
intense negative emotions such as fear, that inhibit pain (Rhudy and Meagher, 2000; 
Rhudy and Meagher, 2001a), may do so via opioid mechanisms (e.g., parachute jumps by 
novices – Janssen and Arntz, 2001; combat movies shown to Vietnam veterans – Pitman 
et al., 1990).  
Administration of opioids may blunt the affective component of pain without 
necessarily dulling the sensation itself (Gutstein and Akil, 2001). In particular, opioid 
release in cortical regions involved in emotional processing appears to suppress the 
emotive element of pain (Zubieta et al., 2001) and affective states such as sadness 
(Zubieta et al., 2003), whereas blocking µ-opioid receptors with naloxone increases 
activity in these regions (Borras et al., 2004). Thus, activation of the endogenous opioid 
system during psychological stress could suppress the affective and sensory components 
of pain independently. The presence of opioid peptides and receptor sites in areas of the 
brain that modulate responses to psychological stress is consistent with this idea (Drolet 
et al., 2001).  
In general, pain sensitivity is greater in women than men (Weisenfeld-Hallin, 
2005). For example, women experience more severe post-operative pain and require 
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more morphine than men to achieve a similar degree of analgesia (Cepeda and Carr, 
2003; Aubrun et al., 2005). This may be due, in part, to a decrease in µ-opioid receptor 
availability and suppression of endogenous opioid responses to pain during low oestrogen 
states (Zubieta et al., 2002; Smith et al., 2006). On the other hand, µ-opioid receptor 
binding is greater in various cortical and subcortical brain regions of women than men 
(Zubieta et al., 1999). Furthermore, placebo analgesia – thought to be mediated by 
endogenous opioid release – and naloxone-induced increases in the stress-hormone 
cortisol are greater in women than men (Pud et al., 2006; Uhart et al., 2006). Therefore, 
effects of µ-opioid receptor blockade on pain and emotional distress may differ between 
the sexes.  
In the present study, the opioid receptor antagonist naltrexone or placebo was 
administered before participants completed a painful cold pressor test and stressful 
mental arithmetic that incorporated painful electric shocks. We expected that the intensity 
of distress generated during mental arithmetic would depend on individual differences in 
the capacity to deal with task demands, and that opioid release would be greatest in the 
most distressed subjects (Bandura et al., 1988). To explore this possibility, changes in 
cold-induced pain after mental arithmetic were investigated in relation to the intensity of 
negative affect. It was hypothesized that naltrexone would alter the relationship between 
negative affect and pain. In addition, it was hypothesized that the effect of naltrexone 
would differ between men and women. 
Method 
Subjects  
The sample consisted of 21 men (mean age 20.9 + 3.2 years) and 22 women 
(mean age 20.4 + 4.8 years) who reported that they were in good health. Exclusion 
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criteria included any previous/current injury to the non-dominant arm which was used for 
pain testing (all participants were right-handed), chronic pain conditions or headache, and 
medical or psychiatric conditions necessitating the use of any form of analgesic, 
antidepressant, anti-anxiety or antihypertensive medication. Subjects were recruited from 
undergraduate psychology classes and the general university population. They were 
asked to refrain from consuming alcoholic or caffeinated beverages for 12 hours before 
the experiment, and food or tobacco for two hours before the experiment. They provided 
informed consent for the procedures, which were approved by the Murdoch University 
Human Research Ethics Committee. Subjects received $15 for their participation. 
Procedures 
Design overview. The experiment was carried out in a temperature-controlled 
laboratory maintained at 22 ± 2°C. Subjects were randomly assigned to the naltrexone 
(10 men and 10 women) or placebo condition (11 men and 12 women). A 50 mg 
naltrexone caplet or a sugar pill was encapsulated and administered double-blind. 
Preliminary analyses indicated that age and sex distributions were similar in each drug 
condition. The experimental timeline is presented in Figure 1. Subjects rated anger, 
discouragement, anxiety and filler items (confusion, sluggishness and liveliness) on 
separate 100 mm visual analogue scales ranging from “not at all” to “extremely” at 
various stages throughout the experiment. They completed a cold pressor test and mood 
ratings before taking the drug, 50-60 minutes later when the drug had been absorbed, and 
shortly after the math task had been completed. During the math task, subjects rated 
mood at intervals of 5-7 minutes starting 1.5 minutes into the task. They also rated the 
pain intensity and unpleasantness of seven electric shocks on 100 mm visual analogue 
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scales ranging from “no pain” or “not unpleasant at all” to “pain as bad as it could get” or 
“as unpleasant as it could get”.  
Cold pressor test. Before the test, the left hand was immersed up to the wrist in a 
37°C water bath for three minutes to standardise hand temperature. The hand was then 
immersed in a 2°C ice-water slurry until the subject felt that cold-induced pain was too 
unpleasant to continue, or until 4 minutes had elapsed. To prevent pockets of warm water 
developing around the hand, a small aquarium pump circulated the ice-water. The female 
experimenter remained in the presence of the subject during the cold pressor test and used 
a stopwatch to measure the duration of immersion. Subjects rated pain intensity and 
unpleasantness at 30-second intervals by moving a slide along a 100 mm visual analogue 
scale. A final rating was made when they withdrew their hand from the ice-water.  
Mental arithmetic. The math task involved addition and subtraction which varied 
across five levels of difficulty: level 1 [e.g., (1 + 3) – 2], level 2 [e.g., (56 + 4) – 6], level 
3 [e.g., (77 + 19) – 2], level 4 [e.g., (245 + 63) – 4], and level 5 [e.g., (771 + 195) – 2]. To 
ensure that the task was difficult, the time limit set for questions at each level was shorter 
than the mean time required to answer these questions in preliminary piloting. Subjects 
were initially presented with problems from Level 3, and the difficulty of the problems 
was automatically adjusted to ensure a 75% failure rate. At the outset of the task subjects 
were told that the number of shocks they would receive depended on their performance; 
that is, poor or slow performers were led to believe that they had a greater chance of 
being shocked. However, so that the number of shocks did not confound results, no such 
contingency existed and all subjects received an identical number of shocks at similar 
stages throughout the task. Subjects initially completed a set of practice trials for 2-3 
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minutes, during which no shocks were delivered. Subjects then rated their ability to avoid 
shocks during the subsequent math task on a 100 mm visual analogue scale delimited by 
“no ability to avoid shocks” and “complete ability to avoid shocks”. This rating averaged 
23.7 + 21.9 mm (S.D.) after the practice trials and did not change greatly thereafter, 
indicating that the task was thought to be extremely difficult. Subjects initiated the rest of 
the task by a keystroke, and were reminded that shocks could be delivered after this 
point. Each math question appeared in yellow 2 cm high numbers in the middle of a black 
computer screen. When solving questions, subjects were instructed to use their left hand 
to type in their answers on the row of numbers at the top of a computer keyboard (and not 
the number-pad) to increase the difficulty of the task. When each problem was 
completed, feedback such as ‘CORRECT’ (green), ‘INCORRECT’ (red) or ‘TOO 
SLOW’ (purple) appeared on the computer screen, and either a pleasant 3-note jingle 
(correct response) or an aversive loud beep (too slow or incorrect response) sounded for 
one second. 
Electric shocks. Seven shocks were delivered at irregular intervals to prevent 
subjects from anticipating their occurrence. When queried after the task, none of the 
subjects reported being aware of the contingency of shock delivery. The shock consisted 
of a 15 mA rectangular pulse of 25 milliseconds duration. Each pulse was delivered by an 
S88 Grass Square Pulse stimulator and constant current unit via 1 cm2 silver/silver 
chloride surface electrodes. The electrodes were filled with water-soluble electrode gel 
and attached 2 cm apart over the right lateral sural nerve behind the lateral malleolus. The 
skin was slightly abraded with a pumice stone and degreased with an alcohol swab to 
achieve skin impedance lower than 10 Kohms. The intensity of pulses was monitored via 
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a custom-built digital current meter. The math task was suspended after each shock whilst 
subjects gave pain intensity and unpleasantness ratings. As with mood ratings, subjects 
were instructed to complete their ratings within 15 seconds or risk receiving an electric 
shock whilst making their rating. This ensured that subjects re-engaged with the math 
task quickly. 
Data reduction. The number of subjects who endured the cold pressor test for the 
entire four minutes did not differ between groups before naltrexone or placebo were 
administered (20% placebo, 20% naltrexone: χ2 (1) = 0.05; p= .83), after drug absorption 
(10% placebo, 8.7% naltrexone: χ2 (1) = 0.02; p=.88), or after the math task (20% 
placebo, 13% naltrexone: χ2 (1) = 0.38; p=.54). Thus, mean pain intensity and pain 
unpleasantness ratings were calculated for each cold pressor test by averaging ratings 
until the tolerance point was reached. Mean ratings of pain intensity and unpleasantness 
were also calculated for the seven electric shocks administered during the math task.  
Statistical approach 
To decrease the likelihood of type 1 errors, sets of dependent variables were 
investigated together in multivariate analyses of variance. Significant multivariate effects 
were then explored in univariate analyses of variance, and Bonferroni adjustments were 
used to control the type 1 error rate when assessing the source of significant interactions. 
Data are reported as the mean + standard error. 
The relationship between pain and negative affect was compared across the 
naltrexone and placebo conditions in hierarchical multiple linear regression analyses. In 
each regression model, the Drug condition (naltrexone or placebo) was dummy-coded 
and entered in the first step. Mood, averaged across the math task, was also entered in the 
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first step, and the interaction term (the product of Drug and Mood) was entered in the 
second step. This interaction tested whether modulation of pain ratings by mood differed 
between the naltrexone and placebo conditions (as might be expected if stress-evoked 
opioid release inhibits pain).  
Mood ratings. To determine whether opioid receptor blockade increased negative 
affect, the effect of naltrexone on anxiety, discouragement and anger was investigated in 
a Drug (naltrexone, placebo) x Sex (male, female) x Time (before versus after drug 
administration) multivariate repeated measures analysis of variance. Changes in negative 
affect during and after the math task were investigated in an additional multivariate 
repeated measures analysis with factors of Drug, Sex and Time (before the task, the five 
measures during the task, and the post-task measure).  
Electrically-evoked pain. It was hypothesized that opioid receptor blockade would 
increase pain ratings to the electric shocks, and that this would differ between men and 
women. These hypotheses were investigated in a Drug (naltrexone, placebo) x Sex (male, 
female) multivariate analysis of variance. The relationship between electrically-evoked 
pain and negative affect was then compared across the naltrexone and placebo conditions 
in hierarchical multiple linear regression analyses, to assess whether stress-evoked opioid 
release inhibited pain.  
Cold-induced pain. We expected that opioid receptor blockade would increase 
cold-induced pain, particularly after psychological stress, and that this would differ 
between men and women. To test these hypotheses, the effect of naltrexone on pain 
intensity and pain unpleasantness was investigated in a Drug (naltrexone, placebo) x Sex 
(male, female) x Time (pre-drug, post-drug, post-math) multivariate repeated measures 
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analysis of variance. Main effects and interactions that involved Time were assessed with 
planned contrasts before and after drug administration (to determine whether changes in 
pain were moderated by naltrexone), and before and after mental arithmetic (to determine 
whether naltrexone moderated effects of psychological stress on pain). The effect of 
naltrexone on pain tolerance was investigated separately because preliminary analyses 
indicated that pain tolerance was unrelated to pain ratings at any stage of the experiment 
(Pearson’s correlation coefficient ranged between -0.12 and 0.21 in the placebo and 
naltrexone groups over the course of the experiment, not significant). Finally, the 
relationship between cold-induced pain and negative affect was compared across the 
naltrexone and placebo conditions in hierarchical multiple linear regression analyses. 
Since the effect of the math task on mood and pain was of interest, changes in mood and 
pain were calculated by subtracting ratings before the math task from ratings after the 
math task. These analyses aimed to assess whether stress-evoked opioid release inhibited 
cold-induced pain.   
Results 
Effect of naltrexone on mood ratings  
Negative affect decreased after drug administration [Pillai’s trace = .723; 
multivariate F(3,37) = 3.23, p<0.05] due to a decrease in anxiety that presumably 
reflected familiarization with the experimental setting [F(1,39) = 8.46, p<0.01] (Figure 
2A). Negative affect increased rapidly during the math task, and persisted after the task 
had finished [Pillai’s trace = .898; multivariate F(18,21) = 10.3, p<0.001]. In particular, 
anxiety [F(6,33)=14.8, p<0.001], discouragement [F(6,33)=24.5, p<0.001] and anger 
[F(6,33)=9.2, p<0.001] all increased during the task (Figure 2). By-and-large, increases in 
negative affect during math were similar in men and women, and naltrexone had no 
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consistent effect on mood (none of the multivariate tests of statistical significance for 
effects that included Sex or Drug was statistically significant). However, in light of the 
findings reported below, it is worth noting that discouragement was greater in women 
than men [F(1,38) = 4.53, p<0.05] (Figure 2B). 
Effect of naltrexone on electrically-evoked pain during the math task 
 The electric shocks were regarded as moderately painful (mean rating 56.2 + 3.4) 
and unpleasant (mean rating 54.4 + 3.6). These ratings did not differ consistently between 
men or women, or between naltrexone and placebo recipients.  
In general, the intensity and unpleasantness of shock-induced pain was greatest in 
subjects who reported most negative affect (Table 1). None of the Drug x Mood 
interactions in hierarchical multiple linear regression analyses achieved statistical 
significance, indicating that administration of naltrexone did not alter the relationship 
between shock-induced pain and negative affect. 
Effect of naltrexone on cold-induced pain 
Pain tolerance decreased after drug administration [from 102 + 11 s to 79 + 11 s, 
F(1,39)=9.41, p<0.01] (Figure 3A), irrespective of whether naltrexone or placebo was 
administered, but did not change further after the math task. On average, pain tolerance 
during the three cold pressor tests was greater in men than women [114 + 15 s versus 65 
+ 15 s, F(1,39)=5.55, p<0.05] (Figure 3A), but no other effect of Sex or Drug on pain 
tolerance was identified at any stage of the experiment.  
Most participants considered the cold pressor test to be moderately or extremely 
painful and unpleasant (Figures 3B and 3C). Naltrexone did not affect pain ratings before 
mental arithmetic, and pain intensity and unpleasantness were similar in men and women. 
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After the math task, pain ratings increased in female naltrexone recipients but not in any 
other group [interaction between Drug, Sex and Time: Pillai’s trace = .252; multivariate 
F(2,38) = 6.41, p<0.01]; this applied both for pain intensity [F(1,39) = 6.58, p<0.05] 
(Figure 3B) and  pain unpleasantness [F(1,39) = 9.55, p<0.01] (Figure 3C). Investigation 
of these interactions indicated that increases in pain intensity were greater in female 
naltrexone than placebo recipients (p<0.05 after Bonferroni correction for multiple 
contrasts among groups). In addition, increases in pain unpleasantness were greater in 
female naltrexone recipients than in any other group (p<0.05 after Bonferroni correction 
for multiple contrasts).  
As noted above, pain tolerance was unrelated to pain ratings, and did not differ 
between the naltrexone and placebo groups. Nevertheless, it is possible that variation in 
duration of the cold pressor test contributed to differences in pain ratings between the 
drug conditions or between men and women. This issue was investigated by entering 
changes in pain tolerance as a covariate in analyses of covariance. The Drug x Sex x 
Time interactions remained statistically significant after the change in pain tolerance was 
entered as a covariate, both for pain intensity [F(1,38) = 6.10, p<0.05] and pain 
unpleasantness [F(1,38) = 8.13, p<0.01]. Thus, changes in pain tolerance did not appear 
to account for the increase in pain ratings in female naltrexone recipients after 
psychological stress. 
As shown in Figure 4, changes in discouragement during the math task were 
associated with changes in pain afterwards in the natrexone group but not in the placebo 
group [Drug x Discouragement interaction, for pain intensity t(39)=2.91, p<0.01; for pain 
unpleasantness t(39)=2.08, p<0.05]. The cell size (N = 10-12) was too small to formally 
 13 
investigate the association between pain and discouragement separately for men and 
women within the placebo and naltrexone conditions. Nonetheless, inspection of Figure 4 
suggests that the slope of this relationship was similar for each sex within each Drug 
condition.  
Changes in anxiety and anger during the math task were not associated with 
changes in cold-induced pain afterwards (Table 2). 
Discussion 
The aim of this experiment was to determine whether naltrexone would alter the 
relationship between negative affect and pain in men and/or women. Consistent with 
previous findings of heightened sensitivity to pain in women (Fillingim and Maixner, 
1995; Weisenfeld-Hallin, 2005), women were less tolerant of cold-induced pain than 
men. Of greater interest, cold-induced pain intensity and unpleasantness increased after 
the math task only in women administered naltrexone. Within the naltrexone condition, 
pain ratings increased most in the most discouraged subjects. In contrast, pain ratings 
were unrelated to discouragement in placebo recipients. Subcortical opioid 
neurotransmission may be diminished in women in low-oestrogen states (Smith et al., 
2006), but this does not account for the present findings. Instead, the findings imply that a 
hyperalgesic effect of psychological distress was tempered by opioid release, particularly 
in women. The effect of naltrexone on cold-induced pain may have been stronger in 
women than men because women generally became more discouraged during 
psychological stress than men.  
Frequent, intense electrical stimuli induce opioid-mediated analgesia (e.g., Hyson 
et al., 1982; Willer and Albe-Fessard, 1980; Willer, Dehen, and Cambier, 1981). In the 
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present study, however, pain induced by brief, intermittent shocks was unaffected by the 
opioid receptor antagonist naltrexone. Instead, the intensity and unpleasantness of shock-
induced pain generally increased in proportion to ratings of anxiety, anger and 
discouragement, irrespective of opioid receptor blockade. According to Rhudy and 
Meagher (2001b), the negative affect and high levels of arousal resulting from intense 
stimulation activate the endogenous opioid system, leading to pain inhibition. 
Conversely, lower levels of negative affect facilitate pain in subjects who are exposed to 
aversive, uncontrollable events. Rhudy and Meagher (2001b) speculated that negative 
emotions of low to moderate intensity increase attention towards and amplify pain via 
neural circuits in the amygdala and periaqueductal grey that also modulate startle 
responses. Alternatively, an increase in the concentration of circulating catecholamines 
during psychological stress (Janssen et al., 1998), or selective attention or misattribution 
of arousal (Janssen, 2002), might heighten sensitivity to pain. Anger is generally 
associated with hyperalgesia (Bruehl et al., 2002; Janssen, Spinhoven, and Brosschot, 
2001), possibly for similar reasons.  
 Opioid-mediated stress-induced analgesia appears to be a by-product of learned 
helplessness or ‘passive coping’, which is an adaptive emotional mode of coping with 
inescapable, threatening or stressful situations (Bandler et al., 2000). This response may 
follow a period of active but unsuccessful engagement with a source of stress, and is 
characterized by quiescence, hypotension, decreased responsiveness to the environment, 
and prolonged opioid-mediated analgesia (Grau et al., 1981; Keay and Bandler, 2001; 
Ribeiro et al., 2005). In the present study high levels of discouragement apparently 
evoked opioid release which, in turn, ‘capped’ painful sensations during the final cold 
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pressor test. In contrast, neither anger nor anxiety modulated cold-induced pain after the 
math task. These findings support the notion that passive resignation triggers opioid 
release more readily than emotions that motivate fight or flight (Keay and Bandler, 
2001). This stress-induced opioid release may suppress hyperalgesia evoked by arousal 
and negative affect (Rhudy and Meagher, 2001b).  
Although opioid receptor blockade affected the subjective experience of cold-
induced pain in women after psychological stress, pain tolerance did not differ between 
naltrexone and placebo recipients and did not change after psychological stress. Pain 
tolerance appears to be influenced by contextual cues, emotions, memory, attention and 
negative expectations about the painful experience (Hirsch and Liebert, 1998; Zelman et 
al., 1991). These factors may explain why pain tolerance decreased in all groups when 
the cold pressor test was repeated after drug administration, and why opioid release did 
not increase pain tolerance in men or women after the math task. Pain tolerance was 
greater in men than women throughout the experiment, possibly because of differences in 
pain sensitivity or because men were aware of being watched by a female experimenter. 
This factor may also have influenced pain ratings in men. 
Contrary to expectations, cold-induced pain did not change after the naltrexone 
administration, prior to psychological stress. The effects of µ-opioid receptor blockade on 
experimental pain are inconsistent, with reports of pain increasing after naloxone 
administration (Buchsbaum et al., 1983; Borras et al., 2004), not changing (El-Sobky et 
al., 1976; Grevert and Goldstein, 1978), or decreasing (Stacher et al., 1988; Al’Absi et 
al., 2004). This inconsistency may be due to individual differences in pain sensitivity 
(Buchsbaum et al., 1983) or could be dose-related. For example, whilst high doses of 
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naloxone enhance dental post-operative pain, low doses induce analgesia (Levine et al., 
1979). The 50 mg dose of naltrexone used in the present study most likely was great 
enough to saturate opioid receptors, because this dose blocks the effects of intravenously-
administered heroin in opiate-dependent individuals (Gonzalez and Brogden, 1988). 
Thus, the findings suggest that cold-induced pain triggered minimal opioid release before 
the math task. Since inescapable pain and stress appear to be potent triggers for 
endogenous opioid release (Keay and Bandler, 2001), perhaps naltrexone initially had 
little effect on cold-induced pain because subjects retained control over the duration of 
stimulation. 
One limitation of the present study is that women were studied at all stages of the 
menstrual cycle, and use of oral contraceptives containing oestradiol was not controlled. 
Smith et al. (2006) reported that activation of endogenous opioid neurotransmission in 
the brain during sustained pain was similar in men and women in a high oestrogen state, 
but was greater in women in high than low oestrogen states. Despite this, fluctuations 
across the menstrual cycle are inconsistent and relatively minor for most forms of 
experimentally-induced pain, including cold-induced pain (Sherman and Le Resche, 
2006; Kowalczyk et al., 2006). If anything, variation in opioid secretion associated with 
fluctuations in brain levels of oestrogen would have obscured sex differences in the 
present study; thus, the effects that were identified are likely to be strong. 
A second methodological limitation is that the duration of the cold pressor test 
was under the participant’s rather than the experimenter’s control, thereby potentially 
influencing pain ratings. We could find no evidence of this in the present study – pain 
tolerance was unrelated to pain ratings throughout the experiment, and effects of 
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psychological stress on pain ratings persisted in female naltrexone recipients after 
variation in pain tolerance was controlled statistically. Nevertheless, to verify that the 
anti-nociceptive effects of opioid release are greater in women than men after 
psychological stress, the present findings need to be replicated in an independent sample.     
 In conclusion, stress-induced opioid modulation of cold-induced pain was 
detected in women but not men. This finding is novel and requires replication, but does 
not support the view that reduced opioid activity in the pain modulation pathways of 
women is solely responsible for sex differences in pain sensitivity. In fact, in some 
circumstances opioid analgesia may be greater in women than men because they are more 
likely to experience emotions linked with passive coping such as discouragement. The 
present findings suggest that opioid neurotransmission suppresses experimentally-
induced pain in discouraged women following a period of psychological stress. 
Additional investigation of this effect in patients with chronic pain may be important. For 
example, it is possible to envisage the development of a vicious circle between pain, 
discouragement and opioid activation that promotes opioid tolerance and the persistence 
of pain (Bruehl et al., 1999). 
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Table 1: Association between mood ratings and shock-induced pain intensity and 
unpleasantness during the math task 
 
 Placebo 
(N=23) 
Naltrexone 
(N=20) 
Pain Intensity   
Anxiety .40 .42 
Discouragement .47* .61** 
Anger .31 .38 
Pain Unpleasantness   
Anxiety .53** .47* 
Discouragement .34 .67*** 
Anger .45* .36 
Pearson’s correlation coefficient statistically significant: *p<.05; **p<01; ***p<.001. 
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Table 2: Association between changes in cold-induced pain and mood after the math task 
 Placebo 
(N=23) 
Naltrexone 
(N=20) 
Change in Pain Tolerance with:   
Change in Anxiety -.04 .29 
Change in Discouragement -.02 -.20 
Change in Anger -.07 .02 
Change in Pain Intensity with:   
Change in Anxiety -.12 -.01 
Change in Discouragement -.28    .53* 
Change in Anger -.21 -.31 
Change in Pain Unpleasantness with:   
Change in Anxiety -.11 -.08 
Change in Discouragement -.05    .50* 
Change in Anger .02 -.12 
Pearson’s correlation coefficient statistically significant: * p<0.05. 
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Figure legends 
Figure 1. Timeline of the experiment. 
Figure 2. Mood ratings (+ S.E.M.) before, during and after the math task. The five ratings 
during the math task were obtained at intervals of 5-7 minutes, starting 1.5 minutes into 
the task. Discouragement during and after the math task was greater in women than men 
(p<0.05), but anger and anxiety did not differ across the Sex or Drug conditions. 
Figure 3. Cold-induced pain tolerance, pain intensity and unpleasantness ratings (+ 
S.E.M.) before and after drug absorption, and after the math task. Pain tolerance was 
greater in men than women throughout the experiment (p<0.05), and decreased after drug 
administration (p<0.05). Pain intensity and unpleasantness increased in female naltrexone 
recipients after the math task (*p<0.05), but not in any other group. 
Figure 4. Association between change in discouragement from before to after the math 
task, and change in the intensity and unpleasantness of cold-induced pain in men (filled 
circles) and women (open circles).  
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